Company Search:
Advanced Search
Sponsored Links
Cellectis SA Company Snapshot
Cellectis SA operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cellectis SA with three other companies in this sector in France: Innate Pharma S.A. (2016 sales of 56.16 million Euro [US$60.32 million] ), Oncodesign Sa (11.20 million Euro [US$12.03 million] ), and Adocia SAS (22.49 million Euro [US$24.15 million] ).

Sales Analysis. Cellectis SA reported sales of 51.01 million Euro (US$54.79 million) for the year ending December of 2016. This represents a decrease of 9.5% versus 2015, when the company's sales were 56.39 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Cellectis SA
  Stock Performance Chart for Cellectis SA
  Stock Data: Recent Stock Performance:
  Current Price (3/17/2017): 22.36
(Figures in Euro)
1 Week 2.1%   13 Weeks 6.7%  
4 Weeks 36.5%   52 Weeks -8.3%  
Cellectis SA Key Data:
  Ticker: ALCLS Country: France
  Exchanges: PAR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 51,007,000
(Year Ending Jan 2017).
Employees: 89
  Currency: Euro Market Cap: 785,279,332
  Fiscal Yr Ends: December Shares Outstanding: 35,119,827
  Share Type: Action Ordinaires Closely Held Shares: 6,141,868
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.